Pathogenic Gram-negative bacteria are numerous and range from aggressive species like Pasteurellapestis to opportunists like Pseudomonas aeruginosa. Some, like Salmonella typhi or the brucelle, always produce generalized infections. Others chiefly involve the mucous membranes with occasional deeper spread, e.g. shigelle and most salmonelle in the intestinal tract, Bordetella pertussis and Hemophilus influenzw in the respiratory tract and Escherichia coli and Neisseria gonorrhea? in the urinary and genital tracts.
The meningococcus provides an interesting intermediate stage in invasiveness. I have stressed the infection of mucous membranes as I am sure that we should now be paying more attention to local factors in immunity, for example to the role of IgA antibody. Bacteria used to be described by biochemists as bags of enzymes. The structure of the bag itself determines whether an organism is Gram-positive or Gram-negative while the nature of an infection and of the host response is greatly affected by the surface pattern of antigens. In Gram-negative species the main components of the wall from the cytoplasm outwards are: cytoplasmic membrane, rigid mucopeptide layer, complex lipopolysaccharide lipoprotein layer and a variable capsule.
The endotoxic 'O' antigens and the superficial 'K' antigens, of which 'Vi' is the best known, have been studied extensively in relation to infection. 'H' antigens seem to be of little importance although useful in taxonomy and diagnosis. Fimbriae are probably not of great importance. Brumfitt et al. (1965) suggested that they might enable bacteria to resist phagocytosis. Buck (1967) found no relation between fimbriation and the ability of strains of Esch. coli to cause urinary tract infection.
How do bacteria appear if regarded as immunogens? They are particulate, although many products are soluble, they enter the body in small numbers but since they are self-replicating the dose may be increased and prolonged. Many endotoxins act as good adjuvants. For example, triple antigen owes its success to the adjuvant action of the B. pertussis it contains. Some bacteria may share antigens with their hosts so that tolerance occurs. Rowley & Jenkin (1962) and Rowley (1966) have suggested that mice are susceptible to Salmonella typhimurium because the two species share a significant antigen so that the mice respond inadequately or slowly to an infection. Thus an anti-mouse serum has opsonic activity for Salmonella typhimurium while rats, which normally resist this organism, become susceptible if made tolerant in neonatal life.
Most of the possible immunological responses to an infection are listed in Table 1 . Although it is convenient to separate humoral and cellular events in order to analyse them, they really form an interlocking sequence of reactions. To stress 
III. Arthus
The hypersensitivity reactions are a reminder that immunological responses may harm the host. It is only the most naive medical student who still thinks that the damage in infections is done by the bacteria. Autoimmunologists know better.
Of the responses listed I shall consider in more detail the killing of bacteria by serum, the role of complement and the problem ofcellular immunity. Finally I shall try to show that these problems are not academic exercises but have clinical relevance. Only Gram-negative bacteria are killed by the antibody complement system and even within a single species, e.g. Escherichia coli, there is a wide range of sensitive and resistant strains. shown that protoplasts from Gram-positive Bacillus subtilis can be lysed.
Tolerance Toxin neutralization the importance of one more than the other is rather like deciding the priority of chickens and eggs. Cells are phylogenetict4ly older but, as students now maintain, older does not mean better.
Cells make antibodies and many of the antibody reactions are clearly directed at increasing phagocytosis though phagocytosis is not an end in itself. Once inside a cell bacteria may be killed, may-multiply or may persist in a dormant state. In the process of being killed and digested some bacterial products may become 'super' antigens. Jenkin (1963) has shown that, with Salmonella typhimurium and mouse peritoneal macrophages, antibody acts not only as an opsonin but also increases the subsequent intracellular killing. The post-Metchnikovian enthusiasm for phagocytosis has led to some neglect of the possible value to the parasite of isolation within a cell. An intracellular organism is protected from antibody, from some antibiotics and, perhaps most important, from other cells. Rowley and his colleagues (Jenkin et al. 1964 , Mclntrye et al. 1967 ) have shown, ingeniously and unequivocally, that macrophages are heterogeneous with respect to their bactericidal capacities. This may be very relevant to the evolution of an infectious process and to the interpretation of in vitro experiments on phagocytosis.
The full sequence of complement components has been worked out on red cells but the action of complement on bacteria is generally thought to be similar. Rother et al. (1964) described three intermediate steps in the bactericidal reaction apparently identical with corresponding steps in the hemolytic reaction. However, as might be expected from the structural and functional differences between bacteria and red cells, some differences in their reactions can be detected.
Since, unlike red cells, bacteria grow and divide, the substrate for complement action may be changing both quantitatively and qualitatively during the course of the reaction. As they pass from the lag to the logarithmic phase of growth bacteria become increasingly sensitive to complement (Davis & Wedgewood 1965) .
Bacteria also differ from red cells in their reactions with lysozyme, with bentonite-absorbed serum, and with IgA antibodies. Sensitive strains of Esch. coli treated with fresh normal serum are lysed rapidly by the combined action of natural antibody (IgM), complement and lysozyme. In the absence of lysozyme both killing and lysis occur but more slowly.
IgA antibodies are said (Heremans et al. 1963 , Ishizaka et al. 1966 ) not to fix complement and certainly red cells agglutinated with IgA antibodies do not lyse when complement is added. However, IgA antibodies will enable complement to lyse bacteria. The key to the difference is in Section ofClinical Immunology and Allergy 287 lysozyme. Whereas IgM antibodies and complement but no lysozyme lyse Esch. coli after some delay, IgA antibodies and complement only act on bacteria in the presence of lysozyme. A suggested explanation is that IgA antibodies fix a small amount of complement, insufficient to lyse a red cell or a bacterium, but sufficient to damage the latter enough to allow lysozyme access to the mucopeptide layer of the wall. Lysozyme has no action on red cells (Adinolfi et al. 1966 ).
Serum treated with bentonite but with adequate amounts of lysozyme and antibody replaced shows a slight fall in hvmolytic activity but a quite disproportionate fall in bactericidal power (Glynn & Milne 1967) . It may be that bentonite reduces the amount of some component of complement to a level which is limiting for bacteriolysis but not for hemolysis. However, the possibility that a new factor is involved has not been ruled out.
Because the analogue of the red cell surface in bacteria is the cytoplasmic membrane, many people have assumed that this is where complement acts. This may be so, since complement lyses protoplasts of B. subtilis (Muschel & Jackson 1966) and produces typical holes seen on electron microscopy of Esch. coli spheroplasts (Bladen et al. 1966) . It is less certain that the bacterial cell membrane is the only or even the primary site of action. The holes in the cell walls of Esch. coli demonstrated by Humphrey & Dourmashkin (Glynn & Milne 1967 ) were thought to be in the outer layers. Humphrey et al. (1967) have since produced holes with complement in layers of lipopolysaccharide spread on glass slides; while Bladen et al. (1967) have produced holes in the lipopolysaccharide layer of veillonella as well as in its cytoplasmic membrane. Recently I have found that the sequence of action is complement then lysozyme, and not the reverse. This fits the view that complement enables lysozyme to penetrate the lipopolysaccharide layer and act on the mucopeptide rather than that lysozyme enables complement to reach the cytoplasmic membrane.
Complement in vivo
Although complement has long been known to have opsonic and bactericidal activities in vitro these have only recently been shown to occur in vivo (Spiegelberg et al. 1963 , Glynn & Milne 1967 .
Miss Medhurst and I injected mice intravenously with live radioactively labelled Esch. coli and measured the total and viable bacterial counts in the blood and various organs at intervals (Glynn & Medhurst 1967) . By using complement-sensitive and resistant strains of Esch. coli and normal and complement (C'5) deficient mice we were able to demonstrate killing of bacteria by complement in the circulating blood.
The proportion of bacteria within the reticuloendothelial system still living after thirty minutes was less in normal than in complementdeficient mice. This could have been due to an intracellular action of complement or to the fact that in the normal mice more bacteria were already killed before they were phagocytosed. So far further experiments have failed to resolve this question. Jenkin's (1963) demonstration that antibody increases intracellular killing makes it likely that complement is also involved.
Although complement is evidently concerned in a number of apparently useful processes in vivo, its overall significance and its evolutionary survival value are still not clear. Maal0e (1948) and Rowley (1954) showed a relation between the in vitro sensitivity to complement of strains of salmonella and Esch. coli and their virulence for guinea-pigs and mice. However, in genetic deficiency in certain components of complement (e.g. C'2 in man, C'5 in mice, C'6 in rabbits, C'? in guinea-pigs) there is no good evidence of any undue susceptibility to infection (Muller-Eberhard 1968) .
Cellular Immunity
After fifty years of experimental infection of mice by species of salmonella two problems stand out: (1) Can reasonable immunity be produced by dead or only by live bacteria? (2) What is the relative importance of cellular and humoral immunity?
Mackaness and his colleagues have produced considerable evidence that mouse immunity to salmonella is the immunity of infection and is not wholly species specific. Mice infected with various species of salmonella were challenged by the intravenous injection of Salmonella enteritidis (1, 9, 12; gm -) . Good protection was obtained if the immunizing infection was due to S. enteritidis, S. gallinarum ((1) 9, 12; -) and S. montevideo (6.7; gms, -) all of which persist in the tissues. S. pullorum (1, 9, 12; -) , which is rapidly eliminated, gave no protection. Alcohol-killed bacteria gave only slight protection.
Rowley and his school (Jenkin & Rowley 1965) have claimed good protection by dead S. typhimurium provided that the labile antigen 05 is preserved. They have shown by absorption experiments that many species of salmonella have unsuspected antigens in common. Kenny & Herzberg (1967) have also protected mice with dead vaccines.
Even if live vaccines are essential for immunity, and they certainly seem better than dead ones, it does not follow that cellular immunity is involved. Live vaccines may give a longer period of stimulation and more antigen. They may avoid the loss of labile antigen in killing procedures and as Smith (1958) has shown, living bacteria may produce antigens in vivo that they do not in vitro.
Apart from the need to use live vaccines, the theory of cell immunity is based on the ability to transfer immunity by cells though not by serum and on the 'heterologous immunity' produced by such organisms as Mycobacterium tuberculosis and Listeria monocytogenes. Rowley (1966) has strongly criticized the reported failures to transfer passive humoral immunity. He points out that the half life of IgM in mice is about two days while the fate of a salmonella infection may not be decided for three weeks. If adequate doses of the right antibody are given repeatedly for long enough, protection can be obtained.
Transfer of immunity by peritoneal exudate cells has been studied in detail by Japanese workers. Mitsuhashi et al. (1967) have also transferred immunity by cell extracts containing ribonucleic acid. Both Kurashige et al. (1967) and Ushiba et al. (1966) found live vaccines more effective than dead, and both have described cell-bound antibody.
After infection with tubercle bacilli, brucella or Listeria monocytogenes, mouse macrophages are better able to phagocytose and kill salmonelle (Jenkin & Rowley 1963) . This increased antibacterial activity, though heterologous in its expression, is specific in origin in the sense that cells primarily stimulated by listeria, for example, respond more readily to further stimulation by listeria than by other bacteria. According to Mackaness this hyperfunctioning of macrophages following an intracellular infection is the major factor in resistance.
A stricter, more specific view of cell immunity demands homology between the stimulating and the challenging organisms and it is difficult to conceive strict specificity without invoking antibody. Macrophages from a normal mouse phagocytose and kill bacteria more readily if the latter are coated with antibody. The hyperactive macrophages from an immune mouse perform no better if antibody is added. According to Rowley this is because at first at any rate they themselves already have a surface coat of antibody. Later the 'immune' macrophages no longer have this cell-bound antibody and for the full expres-sion of their capacities extraneous antibody is necessary.
Close comparison of experiments by the different schools is made difficult by differences in strains of organisms, in techniques and in routes of inoculation for immunization and challenge.
It seems reasonable to conclude that both metabolic hyperfunction of macrophages and the enhancing action of antibody have a role to play. Quantitative assessment of the importance of each in experiments in vivo or in clinical infections is still inadequate.
Some Clinical Examples
The most obvious example is the use of vaccines to prevent typhoid fever. For practical purposes a dead vaccine is preferable but not essential. Reasonably effective agents are now available but how they work is not yet established. Unlike the situation with pertussis, there is no correlation between any known mouse test and the effectiveness in practice of typhoid vaccines (Standfast 1967) .
Patients with typhoid or with chronic pyelonephritis develop tolerance for endotoxin (Neva & Morgan 1950 , McCabe 1963 . How far this modifies the course of these diseases is not known. In acute urinary tract infections there is a little evidence that antibodies have a protective but no curative effect (Sanford et al. 1965 ). Percival et al. (1964) have suggested that a raised titre of antibody to Esch. coli is an indication that the kidney as well as the lower urinary tract has been involved.
Congenital hypogammaglobulinxmias are well documented as causes of infection, usually by Gram-positive organisms. Hobbs et al. (1967) described several patients with IgM deficiency and severe meningococcal infections. Many years ago Fothergill & Wright (1933) showed that the incidence of meningitis due to Hwmophilus influenzw at different ages varied inversely with the bactericidal activity of the blood forthis organism. The bactericidal activity in the first few months of life was assumed to be due to transferred maternal antibody. As is now known, this is predominantly IgG in type so that there is a curious discrepancy between these results and those of Hobbs et al. who found that the meningococcidal activity of cord blood was probably in the IgM fraction.
Recently diarrhceas and respiratory tract infections due to IgA deficiency have been described (South et al. 1968 ).
Infections due to deficiency or inadequacy of polymorphonuclear leucocytes are well known as in agranulocytosis, leukemias or the rarer metabolic errors such as chronic granulomatous disease of childhood (Quie et al. 1967) . It is more difficult to attribute clinical infections to deficiencies in other cells. S Section of Clinical Immunology and Allergy 289 Han et al. (1967) describe an increased incidence of salmonella infections' in patients with malignant lymphomas. Another interesting example is the susceptibility to salmonella infections of patients with sickle cell anemia, acute bartonellosis or malaria. These three diseases are characterized by acute hmemolytic anemia and Kaye et al. (1967) have shown that phagocytosis of red cells by macrophages interferes with their capacity to phagocytose and kill bacteria.
Perhaps the best lesson to be drawn from this survey is the need for a more quantitative approach to the whole subject if, as Wilson & Miles (1964) put it, we are to understand'. . . the present position of immunity with its mixture of established fact, halfknowledge, hopeful guessings and frank bewilderment. .
